Category: Company Announcements

NanoTemper Technologies, announced today the launch of Spectral Shift technology within their Dianthus instrument, built to handle the most challenging affinity-based screenings in drug discovery. This breakthrough technology removes the roadblocks experienced by scientists dealing with really complex molecular interactions often seen in challenging drugs and drug targets like Proteolysis-targeting chimeras (PROTACs), Intrinsically Disordered Proteins (IDPs), or fragment libraries.

NanoTemper Technologies today announced the addition of Static Light Scattering (SLS) to their wildly successful Prometheus Panta, turning their instrument best known for being the new gold standard in protein stability characterization for biologics into a tool that will uplevel the tool kit for any AAV-focused gene therapy scientist.

NanoTemper has been given this year’s TOP 100 seal, an award that honors innovative German small and medium-sized companies. The TOP 100 innovation competition is organized by compamedia, and judging is led by innovation researcher Prof. Dr. Nikolaus Franke and his team.

NanoTemper’s newest Monolith instrument has been awarded the Red Dot Award, an internationally recognized seal of excellence in design. Both bold aesthetics and user-friendly design have always been a core focus in NanoTemper’s product development. NanoTemper’s design approach centers around a researcher’s need to solve big research challenges with tools that are intuitive and easy-to-use.

NanoTemper Technologies, well-known for creating biophysical tools that tackle challenging characterizations, enters the protein production market with the release of Andromeda, an instrument that determines optimal expression levels and thermal stability of recombinant membrane proteins in crude lysates — something unachievable using currently available methods or technologies on their own. As a result, Andromeda increases the efficiency of protein production teams at CROs and Biopharma, who now arrive at purification much faster and with the most stable proteins because they have insights on thermal stability during expression screening.

NanoTemper Technologies and SIRION Biotech, two of Munich’s rapidly growing biotech companies, are lending their support to Adrian Bleninger, a 30-year-old Bavarian sailor, in his bid to qualify for the Vendée Globe, a solo round-the-world yacht race.

For the second year in a row, NanoTemper was named one of the most innovative companies in Germany by Capital magazine. A five out of five star distinction placed NanoTemper in the ranking’s top quartile for innovation. And, with 76 of the 473 award-winning companies hailing from the Munich region, NanoTemper’s global headquarters is in an innovation hotspot.

NanoTemper’s newest Monolith instrument has been awarded the globally renowned iF DESIGN AWARD 2021. User-friendly design has always been a core focus in NanoTemper’s product development. NanoTemper’s design approach — beyond thinking about aesthetics — puts the researcher’s needs at the center, ensuring that instruments not only solve big research challenges but also are intuitive and easy-to-use.

NanoTemper Technologies and PharmAI combine competencies to develop biophysical tools that remove costly and time-consuming guesswork from large datasets.

Prometheus, the new gold standard, now provides clarity to the most challenging stability characterizations